Search

Search Constraints

You searched for: Author/Creator Radford, Jonathan Graff

Search Results

1. [P1–334]: CHARACTERIZATION OF THE CLINICAL AND NEUROIMAGING FEATURES OF PATIENTS WITH DEMENTIA WITH LEWY BODIES ASSOCIATED WITH VARIANTS IN GLUCOCEREBROSIDASE (GBA). (1st July 2017)

2. A global functional network biomarker across aging and dysexecutive Alzheimer's disease. (20th December 2022)

3. Asymmetric caudate hypometabolism in the absence of frontal involvement on FDG‐PET in patients with semantic dementia and behavioral symptoms: Neuroimaging / Optimal neuroimaging measures for early detection. (7th December 2020)

4. Beyond risk of amyloid and tau: Genetics of resilience using GWAS, imaging biomarkers, and longitudinal cognitive data. (1st February 2022)

5. Beyond risk of amyloid and tau: Genetics of resilience using GWAS, imaging biomarkers, and longitudinal cognitive data. (December 2021)

6. CD33, MEF2C, and SORL1 are associated with variability in macroscale functional brain architecture in AD: Neuroimaging / imaging and genetics. (7th December 2020)

7. Evolution of the core clinical features of dementia with Lewy bodies: Neuropsychiatry and behavioral neurology: DLB and FTD ‒ clinical manifestations. (7th December 2020)

8. Genome‐wide association study of tau‐PET: Association of variant near NTNG2 with resistance to tau deposition: Neuroimaging: Imaging genetics. (7th December 2020)

9. Harmonizing machine learning imaging biomarkers – CDESH and the case for harmonization in both MR image and low‐dimensional (scalar) output space. (20th December 2022)

10. IC‐03‐04: Network‐Based TAU Deposition Patterns are Related to Functional Network Failure Largely Via Beta‐Amyloid Across The Alzheimer's Spectrum. (1st July 2016)